Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Cipla
Federal Trade Commission
Boehringer Ingelheim
AstraZeneca
Daiichi Sankyo
Moodys
Citi
Queensland Health

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020636

« Back to Dashboard

NDA 020636 describes VIRAMUNE, which is a drug marketed by Boehringer Ingelheim and is included in three NDAs. It is available from two suppliers. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the VIRAMUNE profile page.

The generic ingredient in VIRAMUNE is nevirapine. There are twenty drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the nevirapine profile page.
Summary for 020636
Tradename:VIRAMUNE
Applicant:Boehringer Ingelheim
Ingredient:nevirapine
Patents:0
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020636
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VIRAMUNE nevirapine TABLET;ORAL 020636 NDA AUTHORIZED GENERIC Roxane Laboratories, Inc. 0054-0459 N 0054-0459-21
VIRAMUNE nevirapine TABLET;ORAL 020636 NDA Boehringer Ingelheim Pharmaceuticals Inc. 0597-0046 N 0597-0046-60

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength200MG
Approval Date:Jun 21, 1996TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Colorcon
Chubb
Mallinckrodt
Harvard Business School
Deloitte
Johnson and Johnson
US Army
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.